| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Aug 17, 2026 | Option exercise(M) | 4K | $6.84 | $24K | 36K |
| Aug 17, 2026 | Option exercise(M) | 4K | $7.80 | $27K | 40K |
| Aug 17, 2026 | Sell(S) | 900 | $109.65 | $99K | 39K |
| Aug 17, 2026 | Sell(S) | 300 | $110.52 | $33K | 39K |
| Aug 17, 2026 | Sell(S) | 3K | $112.01 | $372K | 35K |
| Aug 17, 2026 | Sell(S) | 2K | $112.56 | $279K | 33K |
| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Aug 17, 2026 | Option exercise(M) | 4K | — | $0 | 197K |
| Aug 17, 2026 | Option exercise(M) | 4K | — | $0 | 168K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0000907654-26-000079) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Oruka Therapeutics, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.